WHO ICTRP trial
Efficacy and safety of artesunate and sulfadoxine-pyrimethamine and…
ISRCTN45665690 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN45665690 |
|---|---|
| Public title | Efficacy and safety of artesunate and sulfadoxine-pyrimethamine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in low to moderate sentinel sites in Sudan |
| Primary sponsor | World Health Organization (WHO)/HIV/AIDS, Tuberculosis and Malaria (HTM) - Global Malaria Programme |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Sudan |
| Conditions | Malaria Infections and Infestations Malaria |
| Interventions | Each patient will receive both: 1. Artemether-lumefantrine six consecutive doses according to manufacturer recommendation over three days orally (per os) 2. Artesunate 12 mg/kg over three days per os and sulfadoxine-pyrimethamine 1/2 tablet… |
| Registration date | Aug 15, 2007 |
| Target size | 180 |
| Secondary IDs | RPC220 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: